Transgenic/Knockout Mice
Transgenic/Knockout Mice
批准号:
7081710
负责人:
ASTAR WINOTO
金额:
$23.68万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-15 至 2011-06-30
关键词:
T cell receptoranimal careanimal colonybiomedical facilitybiotechnologycellular immunitydisease /disorder modelgene targetinggenetic polymorphismgenetic promoter elementgenetic straingenetically modified animalsgreen fluorescent proteinshost organism interactionimmunogeneticsimmunoregulationlaboratory mousemajor histocompatibility complexmicroorganism immunologyparasite infection mechanismvirus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability to manipulate the mouse genome through transgenic and knock-out or knock-in technologies
has revolutionized modern Immunology. The purpose of this core facility (Core B) is to integrate the
transgenic and gene targeting approach into the studies of host-pathogen interaction, a major thrust of the
program project "Mouse models for understanding host-pathogen interactions". This
Transgenic/Knockout Mouse Core will provide the critical technical capability to generate and to maintain
transgenic and mutant mice commonly used by two or more investigators of the program project (PPG).
In particular, this Core will complement Core C to provide transgenic mice expressing fluorescent proteins
to be used for imaging studies. Core B will also generate and distribute transgenic strains of mice as
needed by the individual investigator in the PPG. In aim 1, C57Bl/6 transgenic mice expressing
fluorescent genes, whose expression is driven by different promoter/enhancers will be generated and
maintained for use in video imaging experiments. These include mice expressing membrane Cyan
Fluorescent Protein (CFP) in dendritic cells or macrophages and mice with CFP or YFP (Yellow
Fluorescent Protein) expressed in all cell types. In aim 2, knock-out/knock-in mice with genes involved
in innate immunity will be maintained as well as back-crossed to C57BI/6 or Balb/c if necessary. These
mice, including DC- and macrophage-specific FADD-/-, MyD88-/-, IFN-alpha/betaR-/-, TRAIL-R-/-, NK deficient
mice, NKG2D-/-, IL-12/GFP (Green Fluorescent Protein) knock-in and lFN-gamma/GFP knock-in mice, will be
provided to investigators in the PPG for their biochemical, infection or imaging experiments. In aim 3,
Core B will generate and provide transgenic mice for the specific needs of the individual PPG
investigator. Completion of these aims is necessary and essential for the success of the PPG designed to
understand how the immune system interacts with model pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8997965
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8295838
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8436162
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8609544
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
Role of " Apoptotic proteins" Regulation Innate Immunity
-
批准号:7081706
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2006
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6927959
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6603117
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6359738
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6755891
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6515156
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:2712889
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6604315
-
项目类别:
-
资助金额:$28.32万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:2377328
-
项目类别:
-
资助金额:$20.62万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:6376484
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6755892
-
项目类别:
-
资助金额:$28.3万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:7091541
-
项目类别:
-
资助金额:$27.57万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:2896103
-
项目类别:
-
资助金额:$21.94万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6904664
-
项目类别:
-
资助金额:$28.27万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:6173506
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6542008
-
项目类别:
-
资助金额:$28.25万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
海外基金